Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| AbCellera Biologics Inc | ABCL | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 3.91 | 04:51:55 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.91 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 3.84 - 8.05 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 3.91 | USD |
AbCellera Biologics (ABCL) Options Flow Summary
AbCellera Biologics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.13B | 289.36M | - | 38.03M | -146.4M | -0.51 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
AbCellera Biologics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ABCL Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.35 | 4.42 | 3.84 | 4.09 | 1,082,929 | -0.44 | -10.11% |
| 1 Month | 4.70 | 4.7499 | 3.84 | 4.35 | 1,026,384 | -0.79 | -16.81% |
| 3 Months | 5.37 | 5.62 | 3.84 | 4.84 | 1,351,128 | -1.46 | -27.19% |
| 6 Months | 4.33 | 6.055 | 3.84 | 4.89 | 1,430,936 | -0.42 | -9.70% |
| 1 Year | 7.11 | 8.05 | 3.84 | 5.85 | 1,948,160 | -3.20 | -45.01% |
| 3 Years | 29.21 | 36.05 | 3.84 | 10.71 | 1,977,344 | -25.30 | -86.61% |
| 5 Years | 61.00 | 71.91 | 3.84 | 12.49 | 1,892,580 | -57.09 | -93.59% |
AbCellera Biologics Description
| AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners. |
